{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:40:40Z","timestamp":1753886440913},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1007\/s11938-007-0063-6","type":"journal-article","created":{"date-parts":[[2008,3,14]],"date-time":"2008-03-14T03:33:16Z","timestamp":1205465596000},"page":"111-119","source":"Crossref","is-referenced-by-count":5,"title":["Treatment of primary sclerosing cholangitis"],"prefix":"10.1007","volume":"10","author":[{"given":"Daniel","family":"Rost","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Kulaksiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolf","family":"Stiehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,15]]},"reference":[{"key":"63_CR1","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/gut.21.10.870","volume":"21","author":"R.W. Chapman","year":"1980","unstructured":"Chapman RW, Arborgh BA, Rhodes JM, et al.: Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980, 21:870\u2013877.","journal-title":"Gut"},{"key":"63_CR2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/hep.1840100406","volume":"10","author":"R.H. Wiesner","year":"1989","unstructured":"Wiesner RH, Grambsch PM, Dickson ER, et al.: Natural history, prognostic factors, and survival analysis. Hepatology 1989, 10:430\u2013436.","journal-title":"Hepatology"},{"key":"63_CR3","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","volume":"38","author":"U. Broome","year":"1996","unstructured":"Broome U, Olson R, L\u00f6\u00f6f L, et al.: Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996, 38:610\u2013615.","journal-title":"Gut"},{"key":"63_CR4","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(91)70019-T","volume":"100","author":"R. Olsson","year":"1991","unstructured":"Olsson R, Danielsson A, J\u00e4rnebrot G, et al.: Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991, 100:1319\u20131323.","journal-title":"Gastroenterology"},{"key":"63_CR5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00042737-200601000-00012","volume":"18","author":"J. Pohl","year":"2006","unstructured":"Pohl J, Ring A, Stremmel W, Stiehl A: The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis. Eur J Gastroenterol Hepatol 2006, 18:69\u201374.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"63_CR6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","volume":"36","author":"A. Bergquist","year":"2002","unstructured":"Bergquist A, Ekbom A, Olsson R, et al.: Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002, 36:321\u2013327.","journal-title":"J Hepatol"},{"key":"63_CR7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-1999-18","volume":"31","author":"C.Y. Ponsioen","year":"1999","unstructured":"Ponsioen CY, Vrouenraets SM, van Milligen de Wit AW, et al.: Value of brush border cytology for dominant strictures in primary sclerosing cholangitis. Endoscopy 1999, 31:305\u2013309.","journal-title":"Endoscopy"},{"key":"63_CR8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0168-8278(99)80198-6","volume":"30","author":"R. Hultcrantz","year":"1999","unstructured":"Hultcrantz R, Olsson R, Danielsson A, et al.: A three year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. J Hepatol 1999, 30:669\u2013673.","journal-title":"J Hepatol"},{"key":"63_CR9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1055\/s-2005-858105","volume":"43","author":"C. Petersen-Benz","year":"2005","unstructured":"Petersen-Benz C, Stiehl A: Impact of dominant stenoses on the serum level of the tumour marker Ca 19-9 in patients with primary sclerosing cholangitis [in German]. Z Gastroenterol 2005, 43:587\u2013590.","journal-title":"Z Gastroenterol"},{"key":"63_CR10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","volume":"99","author":"K. Burak","year":"2004","unstructured":"Burak K, Angulo P, Pasha TM, et al.: Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 2004, 99:523\u2013526.","journal-title":"Am J Gastroenterol"},{"key":"63_CR11","first-page":"1404","volume":"22","author":"U. Broome","year":"1995","unstructured":"Broome U, L\u00f6fberg R, Veress B, Erikson LS: Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 1995, 22:1404\u20131408.","journal-title":"Hepatology"},{"key":"63_CR12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1440-1827.2005.01845.x","volume":"55","author":"T. Uehara","year":"2005","unstructured":"Uehara T, Hamano H, Kawa S, et al.: Distinct clinico-pathological entity \u2018autoimmune pancreatitis-associated sclerosing cholangitis\u2019. Pathol Int 2005, 55:405\u2013411.","journal-title":"Pathol Int"},{"key":"63_CR13","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/gut.52.5.688","volume":"52","author":"S. Engler","year":"2003","unstructured":"Engler S, Elsing C, Flechtenmacher C, et al.: Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorder. Gut 2003, 52:688\u2013689.","journal-title":"Gut"},{"key":"63_CR14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0168-8278(05)80467-2","volume":"20","author":"A. Stiehl","year":"1994","unstructured":"Stiehl A, Walker S, Stiehl L, et al.: Effects of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3 year pilot study with a placebo-controlled study period. J Hepatol 1994, 20:57\u201364.","journal-title":"J Hepatol"},{"key":"63_CR15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.1840160315","volume":"16","author":"U. Beuers","year":"1992","unstructured":"Beuers U, Spengler U, Kruis W, et al.: Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo controlled trial. Hepatology 1992, 16:707\u2013714.","journal-title":"Hepatology"},{"key":"63_CR16","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","volume":"336","author":"K.D. Lindor","year":"1997","unstructured":"Lindor KD: Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. N Engl J Med 1997, 336:691\u2013695.","journal-title":"N Engl J Med"},{"key":"63_CR17","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1053\/gast.2001.27965","volume":"121","author":"S.A. Mitchell","year":"2001","unstructured":"Mitchell SA, Bansi D, Hunt N, et al.: A preliminary trial of high dose ursodeoxycholic acid in primary sclerosing cholangitis. Gastroenterology 2001, 121:900\u2013907.","journal-title":"Gastroenterology"},{"key":"63_CR18","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1572-0241.2001.03777.x","volume":"96","author":"D.M. Harnois","year":"2001","unstructured":"Harnois DM, Angulo P, Jorgensen RA, et al.: High-dose ursodeoxycholic acid as therapy for patients with primary sclerosing cholangitis. Am J Gastroenterol 2001, 96:1558\u20131562.","journal-title":"Am J Gastroenterol"},{"key":"63_CR19","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","volume":"129","author":"R. Olsson","year":"2005","unstructured":"Olsson R, Boberg KM, Schaffalisky de Muckadell O, et al.: High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study. Gastroenterology 2005, 129:1464\u20131472.","journal-title":"Gastroenterology"},{"key":"63_CR20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1023\/A:1026686530785","volume":"44","author":"P. Sauer","year":"1999","unstructured":"Sauer P, Benz C, Rudolph G, et al.: Influence of cholestasis on absorption of ursodeoxycholic acid. Dig Dis Sci 1999, 44:817\u2013822.","journal-title":"Dig Dis Sci"},{"key":"63_CR21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/hep.20370","volume":"40","author":"D. Rost","year":"2004","unstructured":"Rost D, Rudolph G, Kloeters-Plachky P, Stiehl A: Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis. Hepatology 2004, 40:693\u2013698.","journal-title":"Hepatology"},{"key":"63_CR22","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s10620-006-3180-5","volume":"51","author":"D. Rost","year":"2006","unstructured":"Rost D, Rudolph G, Kloeters-Plachky P, Stiehl A: Effect of colitis and ileoanal pouch on biliary enrichment of ursodeoxycholic acid in primary sclerosing cholangitis. Dig Dis Sci 2006, 51:618\u2013622.","journal-title":"Dig Dis Sci"},{"key":"63_CR23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-2006-933563","volume":"26","author":"S.N. Cullen","year":"2006","unstructured":"Cullen SN, Chapman RW: The medical management of primary sclerosing cholangitis. Semin Liver Dis 2006, 26:52\u201361.","journal-title":"Semin Liver Dis"},{"key":"63_CR24","first-page":"5071","volume":"54","author":"D.L. Earnest","year":"1994","unstructured":"Earnest DL, Holubec H, Wali RK, et al.: Chemoprevention of azomethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid. Cancer Res 1994, 54:5071\u20135074.","journal-title":"Cancer Res"},{"key":"63_CR25","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/0016-5085(88)90013-3","volume":"94","author":"A. Stiehl","year":"1988","unstructured":"Stiehl A, Raedsch R, Rudolph G: Ileal excretion of bile acids: comparison with biliary bile composition and effect of ursodeoxycholic acid treatment. Gastroenterology 1988, 94:1201\u20131206.","journal-title":"Gastroenterology"},{"key":"63_CR26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-134-2-200101160-00008","volume":"134","author":"B.Y. Tung","year":"2001","unstructured":"Tung BY, Emond MJ, Haggitt RC, et al.: Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med 2001, 134:89\u201395.","journal-title":"Ann Intern Med"},{"key":"63_CR27","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2003.50156","volume":"124","author":"D.S. Pardi","year":"2003","unstructured":"Pardi DS, Loftus EV, Kremers WK, et al.: Ursodeoxycholic acid as a chemoprotective agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 2003, 124:889\u2013893.","journal-title":"Gastroenterology"},{"key":"63_CR28","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1365-2036.2005.02650.x","volume":"22","author":"J.M. Wolf","year":"2005","unstructured":"Wolf JM, Rybicki LA, Lashner BA: The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis. Aliment Pharmacol Ther 2005, 22:783\u2013788.","journal-title":"Aliment Pharmacol Ther"},{"key":"63_CR29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-8278(01)00251-3","volume":"36","author":"A. Stiehl","year":"2002","unstructured":"Stiehl A, Rudolph G, Kloeters-Plachky P, et al.: Development of bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. J Hepatol 2002, 36:151\u2013156.","journal-title":"J Hepatol"},{"key":"63_CR30","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jhep.2004.01.002","volume":"40","author":"B. Brandsaeter","year":"2004","unstructured":"Brandsaeter B, Isoniemi H, Broome U, et al.: Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol 2004, 40:815\u2013822.","journal-title":"J Hepatol"},{"key":"63_CR31","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/00365520310005172","volume":"38","author":"K.M. Boberg","year":"2003","unstructured":"Boberg KM, Egeland T, Schrumpf E: Long-term effect of corticoid treatment in primary sclerosing cholangitis patients. Scand J Gastroenterol 2003, 38:991\u2013995.","journal-title":"Scand J Gastroenterol"},{"key":"63_CR32","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0168-8278(98)80316-4","volume":"28","author":"R. Olsson","year":"1998","unstructured":"Olsson R, Bj\u00f6rnsson E, B\u00e4ckman L, et al.: Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers. J Hepatol 1998, 28:426\u2013432.","journal-title":"J Hepatol"},{"key":"63_CR33","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep.20457","volume":"40","author":"M. F\u00e4rkkil\u00e4","year":"2004","unstructured":"F\u00e4rkkil\u00e4 M, Karvonen AL, Nurmi H, et al.: Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial. Hepatology 2004, 40:1379\u20131386.","journal-title":"Hepatology"},{"key":"63_CR34","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jhep.2006.07.022","volume":"45","author":"H. Kulaksiz","year":"2006","unstructured":"Kulaksiz H, Rudolph G, Kloeters-Plachky P, et al.: Biliary candida infections in primary sclerosing cholangitis. J Hepatol 2006, 45:711\u2013716.","journal-title":"J Hepatol"},{"key":"63_CR35","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0016-5085(88)90442-8","volume":"94","author":"C.N. Ghent","year":"1988","unstructured":"Ghent CN, Carruthers SG: Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial. Gastroenterology 1988, 94:488\u2013493.","journal-title":"Gastroenterology"},{"key":"63_CR36","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF01300759","volume":"36","author":"A. Podesta","year":"1991","unstructured":"Podesta A, Lopez P, Terg R, et al.: Treatment of pruritus of primary biliary cirrhosis with rifampin. Dig Dis Sci 1991, 36:216\u2013220.","journal-title":"Dig Dis Sci"},{"key":"63_CR37","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/0016-5085(92)90335-V","volume":"102","author":"L. Bachs","year":"1992","unstructured":"Bachs L, Pares A, Elena M, et al.: Effects of long-term rifampicin administration in primary biliary cirrhosis. Gastroenterology 1992, 102:2077\u20132080.","journal-title":"Gastroenterology"},{"key":"63_CR38","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0016-5085(92)90102-5","volume":"102","author":"N.V. Bergasa","year":"1992","unstructured":"Bergasa NV, Talbot TL, Alling DW, et al.: A controlled trial of naloxone infusions for the prurittus of chronic cholestasis. Gastroenterology 1992, 102:544\u2013549.","journal-title":"Gastroenterology"},{"key":"63_CR39","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.510270307","volume":"27","author":"N.V. Bergasa","year":"1998","unstructured":"Bergasa NV, Schmitt JM, Talbot TL, et al.: Open-label trial of oral nalmefene therapy for pruritus of cholestasis. Hepatology 1998, 27:679\u2013684.","journal-title":"Hepatology"},{"key":"63_CR40","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/gast.1997.v113.pm9322521","volume":"113","author":"F.H. Wolfhagen","year":"1997","unstructured":"Wolfhagen FH, Sternieri E, Hop WC, et al.: Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study. Gastroenterology 1997, 113:1264\u20131269.","journal-title":"Gastroenterology"},{"key":"63_CR41","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00042737-199810000-00010","volume":"10","author":"C. Muller","year":"1998","unstructured":"Muller C, Pongratz S, Pidlich J, et al.: Treatment of pruritus in chronic liver disease with 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial. Eur J Gastroenterol Hepatol 1998, 10:865\u2013870.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"63_CR42","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/BF01296045","volume":"31","author":"R. Grijm","year":"1986","unstructured":"Grijm R, Huibregtse K, Bartelsman J, et al.: Therapeutic investigations in primary sclerosing cholangitis. Dig Dis Sci 1986, 31:792\u2013798.","journal-title":"Dig Dis Sci"},{"key":"63_CR43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0016-5107(87)71475-8","volume":"33","author":"G.K. Johnson","year":"1987","unstructured":"Johnson GK, Geenen JE, Venu RP, Hogan WJ: Endoscopic treatment of biliary duct strictures in sclerosing cholangitis: follow-up assessment of a new therapeutic approach. Gastrointest Endosc 1987, 33:9\u201312.","journal-title":"Gastrointest Endosc"},{"key":"63_CR44","first-page":"661","volume":"21","author":"J.G. Lee","year":"1995","unstructured":"Lee JG, Schutz SM, England RE, et al.: Endoscopic therapy of sclerosing cholangitis. Hepatology 1995, 21:661\u2013667.","journal-title":"Hepatology"},{"key":"63_CR45","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0016-5107(96)70167-0","volume":"44","author":"A.W. Milligen de Wit Van","year":"1996","unstructured":"Van Milligen de Wit AW, van Bracht J, Rauws EA, et al.: Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis. Gastrointest Endosc 1996, 44:293\u2013299.","journal-title":"Gastrointest Endosc"},{"key":"63_CR46","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0168-8278(97)80421-7","volume":"26","author":"A. Stiehl","year":"1997","unstructured":"Stiehl A, Rudolph G, Sauer P, et al.: Efficacy of ursodeoxycholic acid and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study. J Hepatol 1997, 26:560\u2013566.","journal-title":"J Hepatol"},{"key":"63_CR47","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1111\/j.1572-0241.1999.01364.x","volume":"94","author":"C.Y. Ponsioen","year":"1999","unstructured":"Ponsioen CY, Lam K, van Milligen de Wit AW, et al.: Four years experience with short-term stenting in primary sclerosing cholangitis. Am J Gastroenterol 1999, 94:2403\u20132407.","journal-title":"Am J Gastroenterol"},{"key":"63_CR48","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1572-0241.2001.03690.x","volume":"96","author":"M. Kaya","year":"2001","unstructured":"Kaya M, Petersen BT, Angulo P, et al.: Balloon dilatation compared to stenting of dominant strictures in primary sclerosing cholangitis. Am J Gastroenterol 2001, 96:1059\u20131066.","journal-title":"Am J Gastroenterol"},{"key":"63_CR49","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0016-5107(01)70403-8","volume":"53","author":"A.R. Baluyut","year":"2001","unstructured":"Baluyut AR, Sherman S, Lehman GA, et al.: Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis. Gastrointest Endosc 2001, 53:308\u2013312.","journal-title":"Gastrointest Endosc"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-007-0063-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-007-0063-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-007-0063-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:36Z","timestamp":1559436996000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-007-0063-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["63"],"URL":"https:\/\/doi.org\/10.1007\/s11938-007-0063-6","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}